Broncho-Vaxom, for children, OM Pharma, 3.5 mg, 10 capsules
| Composition: | ||
| Serving Size: 1 capsule | ||
| Servings Per Container: 10 | ||
| In one daily serving: | % of Daily Value | |
| Standardized lyophilisate of bacterial lysates (Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Streptococcus viridans, Klebsiella pneumoniae, Klebsiella ozaenae, Staphylococcus aureus, Moraxella catarrhalis) | 3.5mg |
Thanks to the immunopharmacological studies, it was determined that Broncho-Vaxom for children has the following characteristics:
- Increases the level of immunoglobulin A (IgA) secreted by the mucous membrane of the respiratory tract and saliva.
The vast surfaces of the gastrointestinal, respiratory and genitourinary tracts represent major sites of potential attack by invading microorganisms. Immunoglobulin A (IgA), as the main class of antibodies in the secretions that bathe these mucous membranes, acts as an important first line protection. IgA, also an important serum immunoglobulin, mediates many protective functions through interaction with specific receptors and immune mediators. T cells are part of the immune system that focuses on certain foreign particles. Instead of attacking any antigen, T cells circulate until they encounter their specific antigen. Thus, T-cells play a decisive role in immunity to foreign substances.
On the Biotus website you can also not only buy, but also get acquainted with the products, get full information from our consultants.
Suggested use:
Broncho-Vaxom® for children is indicated for children aged 6 months to 12 years . The course includes 3 cycles, each of which consists of taking 1 capsule daily for 10 days, the interval between cycles is 20 days. For children under the age of 3 years or if it is difficult for a child to swallow a capsule, it should be opened and the contents mixed with a drink ( water, fruit juice, milk).042 mg, sodium glutamate - 1.515 mg, mannitol - to obtain 20 mg, pregelatinized starch - 110 mg, magnesium stearate - 3 mg, mannitol - to obtain 200 mg. The composition of the capsule shell: indigo carmine (indigotine) dye (E132) - 0.01 mg, titanium dioxide (E171) - 1 mg, gelatin - to obtain 50 mg.
Warning:
Broncho-Vaxom® for children is usually well tolerated. Most adverse reactions are categorized as moderate or moderately severe. The most common manifestations of side effects of the drug are skin reactions, disorders of the digestive tract and respiratory organs. From the digestive system: often - diarrhea, abdominal pain; unknown - vomiting, nausea. From the nervous system: unknown - headache. From the respiratory system: often - cough. Dermatological reactions: often - rash. Allergic reactions: infrequently - hypersensitivity reactions (erythematous rash, generalized rash, erythema, swelling of the eyelids , swelling of the face, peripheral edema, swelling of the face, itching, generalized itching, shortness of breath); unknown - urticaria, Quincke's edema. Others: unknown - fever, fatigue. Contraindications for use: hypersensitivity to the components of the drug. Broncho-Vaxom® for children should not be used in children under 6 months of age. other drugs for the treatment of acute and chronic respiratory diseases. The drug should be stored out of the reach of children at a temperature of 15 ° to 25 ° C.
Keep your rhythm with the My Nutri Week brand!
I remembered my password